It has been demonstrated that c-MYC activation is strongly correlated with phosphorylated AKT1 expression and that HCC patients with relatively higher expression of AKT1, but not AKT2, have an unfavorable outcome [30]. This evidence concerns the gene MYC and hepatocellular carcinoma.